Stay updated on Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.

Latest updates to the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page's revision metadata was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.3 was added to the history. Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Revision: v3.4.2 to the study record history. Removed the government-funding notice and Revision: v3.4.1 entry.SummaryDifference0.6%

- Check69 days agoChange DetectedA government funding lapse notice was added to the page, warning that data may not be up to date, and the revision version was updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check76 days agoChange DetectedGlossary visibility is added to the page, and UI highlights now color-code additions in green and deletions in red. The revision stamp updated to Revision: v3.4.0.SummaryDifference0.8%

- Check90 days agoChange DetectedNew entry Revision: v3.3.4 was added and Revision: v3.3.3 was removed from the Record History. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.